Anaptysbio (ANAB) Capital Expenditures (2016 - 2026)
Anaptysbio posted quarterly Capital Expenditures of $17000.0 for Q1 2026, down 51.43% year-on-year from $35000.0 in Q1 2025, and up 1600.0% on a QoQ basis from $1000.0 in Q4 2025.
Anaptysbio (ANAB) has 11 years of Capital Expenditures data on file, last reported at $17000.0 in Q1 2026.
- For the quarter ending Q1 2026, Capital Expenditures fell 51.43% year-over-year to $17000.0; the trailing twelve-month figure through Mar 2026 stood at $69000.0 (down 81.15% YoY), and the FY2025 full-year result was $87000.0, down 75.7% from the prior year.
- Capital Expenditures for Q1 2026 stood at $17000.0, up from $1000.0 in the prior quarter.
- Across five years, Capital Expenditures topped out at $528000.0 in Q4 2023 and bottomed at -$123000.0 in Q2 2023.
- The 5-year median for Capital Expenditures is $35000.0 (2024), against an average of $83705.9.
- Peak annual rise in Capital Expenditures reached 821.05% in 2023, while the deepest fall reached 207.89% in 2023.
- A 5-year view of Capital Expenditures shows it stood at $126000.0 in 2022, then soared by 319.05% to $528000.0 in 2023, then slumped by 50.19% to $263000.0 in 2024, then sank by 99.62% to $1000.0 in 2025, then surged by 1600.0% to $17000.0 in 2026.
- The last three Capital Expenditures figures came in at $17000.0 (Q1 2026), $1000.0 (Q4 2025), and $12000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 133.40 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 230.60 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 21.83 Mn |
| 10 | Anaptysbio | 1.60 Bn | 1.31 Bn | - | 17,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 17,000.00 |
| Mar 31, 2026 | 17,000.00 |
| Dec 31, 2025 | 1,000.00 |
| Dec 31, 2025 | 1,000.00 |
| Sep 30, 2025 | 12,000.00 |
| Sep 30, 2025 | 12,000.00 |
| Jun 30, 2025 | 39,000.00 |
| Jun 30, 2025 | 39,000.00 |
| Mar 31, 2025 | 35,000.00 |
| Mar 31, 2025 | 35,000.00 |
| Dec 31, 2024 | 263,000.00 |
| Dec 31, 2024 | 263,000.00 |
| Sep 30, 2024 | 35,000.00 |
| Sep 30, 2024 | 35,000.00 |
| Jun 30, 2024 | 33,000.00 |
| Jun 30, 2024 | 33,000.00 |
| Mar 31, 2024 | 27,000.00 |
| Mar 31, 2024 | 27,000.00 |
| Dec 31, 2023 | 528,000.00 |
| Dec 31, 2023 | 528,000.00 |
| Sep 30, 2023 | 227,000.00 |
| Sep 30, 2023 | 227,000.00 |
| Jun 30, 2023 | -123,000.00 |
| Jun 30, 2023 | -123,000.00 |
| Mar 31, 2023 | 175,000.00 |
| Mar 31, 2023 | 175,000.00 |
| Dec 31, 2022 | 126,000.00 |
| Dec 31, 2022 | 126,000.00 |
| Sep 30, 2022 | -105,000.00 |
| Sep 30, 2022 | -105,000.00 |
| Jun 30, 2022 | 114,000.00 |
| Jun 30, 2022 | 114,000.00 |
| Mar 31, 2022 | 19,000.00 |
| Mar 31, 2022 | 19,000.00 |
| Dec 31, 2021 | 20,000.00 |
| Dec 31, 2021 | 20,000.00 |
| Sep 30, 2021 | -1.17 Mn |
| Sep 30, 2021 | -1.17 Mn |
| Jun 30, 2021 | 863,000.00 |
| Jun 30, 2021 | 863,000.00 |
| Mar 31, 2021 | 317,000.00 |
| Mar 31, 2021 | 317,000.00 |
| Dec 31, 2020 | 404,000.00 |
| Dec 31, 2020 | 404,000.00 |
| Sep 30, 2020 | -5,000.00 |
| Sep 30, 2020 | -5,000.00 |
| Jun 30, 2020 | 84,000.00 |
| Jun 30, 2020 | 84,000.00 |
| Mar 31, 2020 | 86,000.00 |
| Mar 31, 2020 | 86,000.00 |
| Dec 31, 2019 | 723,000.00 |
| Dec 31, 2019 | 723,000.00 |
| Sep 30, 2019 | 68,000.00 |
| Sep 30, 2019 | 68,000.00 |
| Jun 30, 2019 | -219,000.00 |
| Jun 30, 2019 | -219,000.00 |
| Mar 31, 2019 | 233,000.00 |
| Mar 31, 2019 | 233,000.00 |
| Dec 31, 2018 | -698,000.00 |
| Dec 31, 2018 | -698,000.00 |
| Sep 30, 2018 | 663,000.00 |
| Sep 30, 2018 | 663,000.00 |
| Jun 30, 2018 | 187,000.00 |
| Jun 30, 2018 | 187,000.00 |
| Mar 31, 2018 | 7,000.00 |
| Mar 31, 2018 | 7,000.00 |
| Dec 31, 2017 | 179,000.00 |
| Dec 31, 2017 | 179,000.00 |
| Sep 30, 2017 | -141,000.00 |
| Sep 30, 2017 | -141,000.00 |
| Jun 30, 2017 | 68,000.00 |
| Jun 30, 2017 | 68,000.00 |
| Mar 31, 2017 | 85,000.00 |
| Mar 31, 2017 | 85,000.00 |
| Dec 31, 2016 | 55,000.00 |
| Dec 31, 2016 | 55,000.00 |
| Sep 30, 2016 | 49,000.00 |
| Sep 30, 2016 | 49,000.00 |
| Jun 30, 2016 | -7,000.00 |
| Jun 30, 2016 | -7,000.00 |
| Mar 31, 2016 | 7,000.00 |
| Mar 31, 2016 | 7,000.00 |